PREVENTION OF DIROPHILARIOSIS
Administered within the month of the host's activity (mosquito), it has demonstrated persistent efficacy during the seasonal period of risk of filariosis caused by D. immitis and skin lesions caused by D. repens in Europe.
This product is no longer in stock
Moxidectin 3.4 mg / ml
Powder, solvent for suspension for injection + adapter
ROUTE OF ADMINISTRATION
Prevention of filariosis (larvae L3 and L4 of Dirofilaria immittis).
Prevention of skin lesions and dermatitis caused by Dirofilaria repens (larvae L3).
Treatment of infections caused by larvae or adults of Ancylostomum caninum and Uncinaria stenocephala present at the time of treatment.
0.17 mg moxidectin / kg body weight at a single dose, equivalent to 0.05 ml of reconstituted suspension / kg body weight.
20 ml reconstitution vial + adapter
No customer reviews for the moment.